Humana needed to accelerate their data science and AI capabilities in-house, as well as provide access to granular level data to third-party vendors. However, the lack of proper security in the cloud to handle sensitive data, including PII and PHI slowed things down and made innovation near-impossible. Exchanging health data with research teams and health application developers, who needed realistic test data was out of the question. At the beginning of the synthetic health data adoption, the company’s 200-people strong data science team was also struggling to access sensitive health data in dynamic ways.
Humana’s Data Exchange Platform offers 1,5 million synthetic health data records with 700 variables. In the first year since its launch, 8+ new products were developed by third party vendors using the synthetic health data provided via the platform.